(Q43220830)

16 November 2017

title

Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study (English)

1 reference

16 November 2017

0 references

2

M A Banerji

1 reference

16 November 2017

1

R A DeFronzo

1 reference

16 November 2017

G A Bray

3

1 reference

16 November 2017

T A Buchanan

4

1 reference

16 November 2017

S Clement

5

1 reference

16 November 2017

R R Henry

6

1 reference

16 November 2017

A E Kitabchi

7

1 reference

16 November 2017

S Mudaliar

8

1 reference

16 November 2017

N Musi

9

1 reference

16 November 2017

R Ratner

10

1 reference

16 November 2017

P Reaven

11

1 reference

16 November 2017

D C Schwenke

12

1 reference

16 November 2017

F D Stentz

13

1 reference

16 November 2017

D Tripathy

14

1 reference

16 November 2017

ACT NOW Study Group

15

1 reference

16 November 2017

publication date

10 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

53

1 reference

16 November 2017

issue

3

1 reference

16 November 2017

page(s)

435-445

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1614-2

16 November 2017

exact match

0 references

cites work

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-009-1614-2

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

21 January 2018

1 reference

12 December 2020

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

1 reference

12 December 2020

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin

1 reference

12 December 2020

Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

1 reference

12 December 2020

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

1 reference

12 December 2020

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes

1 reference

12 December 2020

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

12 December 2020

The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program

1 reference

12 December 2020

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study

1 reference

12 December 2020

Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.

1 reference

12 December 2020

Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes

1 reference

12 December 2020

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

1 reference

12 December 2020

Follow-up report on the diagnosis of diabetes mellitus

1 reference

12 December 2020

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

1 reference

12 December 2020

Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program

1 reference

12 December 2020

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes

1 reference

12 December 2020

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

1 reference

12 December 2020

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

1 reference

12 December 2020

Accurate assessment of beta-cell function: the hyperbolic correction

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy

1 reference

12 December 2020

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

1 reference

12 December 2020

Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes

1 reference

12 December 2020

10.1007/S00125-009-1614-2

Identifiers

DOI

1 reference

16 November 2017

1 reference